Improved ASCVD Screening in Diabetes: a Focus on Scoring Models and Detection Techniques

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Diseases

Background:

• Atherosclerotic cardiovascular disease (ASCVD) is a primary cause of death in type 2 diabetes mellitus (T2DM) patients.
• Diabetes accelerates atherosclerosis via insulin resistance, hyperglycemia, dyslipidemia, inflammation, and oxidative stress.
• Existing risk models inadequately address residual cardiovascular risk in T2DM.

Purpose of the Study:

• To review the pathophysiological links between T2DM and ASCVD.
• To highlight the need for enhanced screening protocols in diabetic populations.
• To discuss advanced risk assessment tools and emerging therapeutic strategies.

Main Methods:

• Review of current literature on T2DM, atherosclerosis, and cardiovascular risk.
• Examination of pathophysiological mechanisms linking diabetes and ASCVD.
• Evaluation of advanced screening techniques and novel therapeutic targets.

Main Results:

• T2DM significantly increases ASCVD risk through multiple metabolic and inflammatory pathways.
• Non-invasive imaging (e.g., coronary artery calcium scoring, CCTA) and biomarkers (e.g., polygenic risk scores) show promise for early detection.
• Therapeutic strategies targeting inflammation and insulin resistance are under investigation.

Conclusions:

• Enhanced screening protocols and advanced risk stratification are essential for T2DM patients.
• Novel diagnostic tools and therapeutic approaches are needed to reduce ASCVD morbidity and mortality.
• Addressing residual cardiovascular risk in T2DM requires a multi-faceted approach.